T LYMPHOBLASTIC LYMPHOMA
Clinical trials for T LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New chemo cocktail aims to beat tough blood cancers
Disease control Recruiting nowThis study tests a powerful mix of chemotherapy drugs plus nelarabine in people with untreated T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma. The goal is to see how well the treatment kills cancer cells and what side effects occur. About 160 adults will take part,…
Matched conditions: T LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
Double-Targeted CAR-T therapy takes on relapsed blood cancers
Disease control Recruiting nowThis study tests a new type of CAR-T cell therapy that targets two different markers on cancer cells at once. It is for adults with blood cancers like leukemia, lymphoma, or myeloma that have come back or not responded to other treatments. The goal is to see if this dual-target a…
Matched conditions: T LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 26, 2026 12:03 UTC